June 17, 2025

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 30% Potential Upside

Haemonetics Corporation (NYSE: HAE), a stalwart in the healthcare sector, is attracting significant attention from investors with its robust market position in the medical devices industry...

CG Oncology, Inc. (CGON)

⚠️ No article content returned.

..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Exploring a Promising 180% Upside Potential

For individual investors seeking opportunities within the biotechnology sector, Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) presents an intriguing proposition. With a market capitalization of $2.17 billion, Arrowhead..

NovoCure Limited (NVCR): Investor Outlook Reveals an 81.91% Potential Upside

In the realm of medical devices, NovoCure Limited (NASDAQ: NVCR) stands out as a significant player, not just for its innovative approach to cancer treatment but..

Belite Bio, Inc (BLTE) Stock Analysis: Uncovering a 41.69% Potential Upside in the Biotech Arena

Belite Bio, Inc (NASDAQ: BLTE) is capturing attention in the biotechnology sector, driven by its innovative approach to addressing significant unmet medical needs. With a market..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unveiling a 264% Potential Upside for Biotech Investors

ImmunityBio, Inc. (IBRX) stands at the forefront of cutting-edge biotechnology innovation, as it continues to make significant strides in developing therapies that enhance the immune system’s..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare Challenges with a 3.77% Dividend Yield

Premier, Inc. (NASDAQ: PINC) stands as a significant player in the healthcare sector, specifically within the Health Information Services industry. Headquartered in Charlotte, North Carolina, Premier’s..

Disc Medicine, Inc. (IRON) Stock Analysis: Exploring an 88.91% Potential Upside in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON) is creating a buzz in the biotechnology sector with its promising pipeline and significant upside potential for investors. With a current..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 61.34% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL) stands as a noteworthy player in the healthcare sector, specializing in medical devices and diagnostic testing solutions. With a market capitalization of..

Galapagos NV (GLPG) Stock Analysis: Navigating a Path with Limited Upside

For investors keen on exploring opportunities in the biotechnology sector, Galapagos NV (GLPG), headquartered in Mechelen, Belgium, presents a unique case. Specializing in developing innovative medicines..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Is a 120% Upside Within Reach for This Biotech Pioneer?

Apogee Therapeutics, Inc. (APGE), a biotechnology firm rooted in the healthcare sector, is making waves with its promising portfolio of innovative treatments for various inflammatory and..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating a Challenging Landscape with Strategic Potential

Envista Holdings Corporation (NYSE: NVST) remains a company to watch in the healthcare sector, specifically within the realm of medical instruments and supplies. With a market..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring a 25.69% Upside Potential Amidst Biotech Growth

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a cutting-edge biopharmaceutical company focused on developing innovative peptide therapeutics, has been gaining significant attention from investors. With a market capitalization..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Strong Buy Ratings and 66% Potential Upside in Medical Devices Sector

Alphatec Holdings, Inc. (NYSE: ATEC), a prominent player in the healthcare sector specializing in medical devices, has emerged as a company of interest for investors seeking..

Sotera Health Company (SHC) Stock Analysis: A 31% Potential Upside Beckons Investors

Sotera Health Company (NASDAQ: SHC), a prominent player in the healthcare sector’s diagnostics and research industry, presents a compelling case for investors seeking growth potential amidst..

HUTCHMED (HCM) Stock Analysis: Unpacking a 52.88% Potential Upside for Savvy Investors

In the ever-evolving landscape of the healthcare sector, HUTCHMED (China) Limited (HCM) stands out with its significant potential upside of 52.88%, as suggested by analyst ratings...

Ligand Pharmaceuticals (LGND) Stock Analysis: Strong Buy Ratings and a 25% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands as a compelling investment opportunity in the biotechnology sector, with a market capitalization of $2.22 billion. The company, based in..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: A Biotech Pioneer with 18.89% Potential Upside

PTC Therapeutics, Inc. (NASDAQ: PTCT) is a force to be reckoned with in the biotechnology sector, commanding a market capitalization of $4.11 billion. As a company..

NewAmsterdam Pharma (NAMS) Stock Analysis: A 117.83% Upside in the Healthcare Sector

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a notable player in the biotechnology industry, has been capturing investor attention with its promising pipeline and impressive potential upside...

Vericel Corporation (VCEL) Stock Analysis: Why a 42.76% Potential Upside Could Entice Investors

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, is capturing investor attention due to its promising growth potential. With a market capitalization of..

Search

Funds

June 17, 2025

Search

Funds

June 17, 2025

FTSE 100

Funds